A phase II randomized open-label study anti-CMV hyperimmune globulin vs standard IGIV for prevention of cytomegalovirus (CMV) reactivation in hypogammaglobulinemic adult allogeneic hematopoietic stem cell transplants (AHSCT)

✍ Scribed by J.S. Bubalo; J.F. Leis; P.T. Curtin; A. Simic; N. Subbiah; C. Fowler; A. Dunn; B. Grant; R.T. Maziarz

• Book ID: 116278961
• Publisher: Elsevier Science
• Year: 2006
• Tongue: English
• Weight: 66 KB
• Volume: 12
• Category: Article
• ISSN: 1083-8791
• DOI: 10.1016/j.bbmt.2005.12.015